vs
豪洛捷（HOLX）与RPM INTERNATIONAL INC（RPM）财务数据对比。点击上方公司名可切换其他公司
RPM INTERNATIONAL INC的季度营收约是豪洛捷的1.8倍（$1.9B vs $1.0B），豪洛捷净利率更高（17.1% vs 8.4%，领先8.7%），RPM INTERNATIONAL INC同比增速更快（3.5% vs 2.5%），RPM INTERNATIONAL INC自由现金流更多（$296.4M vs $215.2M），过去两年RPM INTERNATIONAL INC的营收复合增速更高（12.0% vs 1.5%）
豪洛捷是一家总部位于美国的医疗科技企业，核心业务聚焦女性健康领域，旗下产品涵盖诊断、外科手术及医学影像类专业医疗设备，为全球各地的医疗场景提供优质技术与产品支持。
BVS娱乐前身为Saban制作、Saban国际及Saban娱乐，是华特迪士尼公司旗下子公司。1980年4月24日由哈伊姆·萨班与舒基·利维创立，最初主营音乐制作，后逐步转向电视节目制作发行业务，最为知名的是为Fox Family/ABC Family及已停播的Fox Kids、Jetix频道制作发行儿童节目。
HOLX vs RPM — 直观对比
营收规模更大
RPM
是对方的1.8倍
$1.0B
营收增速更快
RPM
高出1.0%
2.5%
净利率更高
HOLX
高出8.7%
8.4%
自由现金流更多
RPM
多$81.2M
$215.2M
两年增速更快
RPM
近两年复合增速
1.5%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.9B |
| 净利润 | $179.1M | $161.2M |
| 毛利率 | 56.0% | 40.8% |
| 营业利润率 | 22.6% | 11.0% |
| 净利率 | 17.1% | 8.4% |
| 营收同比 | 2.5% | 3.5% |
| 净利润同比 | -10.9% | -12.0% |
| 每股收益（稀释后） | $0.79 | $1.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HOLXRPM
| Q4 25 | $1.0B | $1.9B | ||
| Q3 25 | $1.0B | $2.1B | ||
| Q2 25 | $1.0B | $2.1B | ||
| Q1 25 | $1.0B | $1.5B | ||
| Q4 24 | $1.0B | $1.8B | ||
| Q3 24 | $988.0M | $2.0B | ||
| Q2 24 | $1.0B | $2.0B | ||
| Q1 24 | $1.0B | $1.5B |
净利润HOLXRPM
| Q4 25 | $179.1M | $161.2M | ||
| Q3 25 | $187.2M | $227.6M | ||
| Q2 25 | $194.9M | $225.8M | ||
| Q1 25 | $-17.4M | $52.0M | ||
| Q4 24 | $201.0M | $183.2M | ||
| Q3 24 | $178.6M | $227.7M | ||
| Q2 24 | $194.5M | $180.6M | ||
| Q1 24 | $169.9M | $61.2M |
毛利率HOLXRPM
| Q4 25 | 56.0% | 40.8% | ||
| Q3 25 | 55.6% | 42.3% | ||
| Q2 25 | 56.3% | 42.4% | ||
| Q1 25 | 37.5% | 38.4% | ||
| Q4 24 | 56.8% | 41.4% | ||
| Q3 24 | 56.4% | 42.5% | ||
| Q2 24 | 55.4% | 41.4% | ||
| Q1 24 | 53.3% | 39.9% |
营业利润率HOLXRPM
| Q4 25 | 22.6% | 11.0% | ||
| Q3 25 | 22.6% | 14.1% | ||
| Q2 25 | 24.9% | 11.9% | ||
| Q1 25 | -0.7% | 2.8% | ||
| Q4 24 | 22.5% | 11.5% | ||
| Q3 24 | 23.3% | 14.8% | ||
| Q2 24 | 24.1% | 11.9% | ||
| Q1 24 | 20.7% | 5.5% |
净利率HOLXRPM
| Q4 25 | 17.1% | 8.4% | ||
| Q3 25 | 17.8% | 10.8% | ||
| Q2 25 | 19.0% | 10.8% | ||
| Q1 25 | -1.7% | 3.5% | ||
| Q4 24 | 19.7% | 9.9% | ||
| Q3 24 | 18.1% | 11.6% | ||
| Q2 24 | 19.2% | 9.0% | ||
| Q1 24 | 16.7% | 4.0% |
每股收益（稀释后）HOLXRPM
| Q4 25 | $0.79 | $1.26 | ||
| Q3 25 | $0.84 | $1.77 | ||
| Q2 25 | $0.86 | $1.76 | ||
| Q1 25 | $-0.08 | $0.40 | ||
| Q4 24 | $0.87 | $1.42 | ||
| Q3 24 | $0.75 | $1.77 | ||
| Q2 24 | $0.82 | $1.40 | ||
| Q1 24 | $0.72 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | $316.6M |
| 总债务越低越好 | $2.5B | $2.5B |
| 股东权益账面价值 | $5.2B | $3.1B |
| 总资产 | $9.2B | $7.9B |
| 负债/权益比越低杠杆越低 | 0.48× | 0.80× |
8季度趋势，按日历期对齐
现金及短期投资HOLXRPM
| Q4 25 | $2.4B | $316.6M | ||
| Q3 25 | $2.2B | $297.1M | ||
| Q2 25 | $1.9B | $302.1M | ||
| Q1 25 | $1.6B | $241.9M | ||
| Q4 24 | $2.0B | $268.7M | ||
| Q3 24 | $2.3B | $231.6M | ||
| Q2 24 | $2.4B | $237.4M | ||
| Q1 24 | $2.2B | $248.9M |
总债务HOLXRPM
| Q4 25 | $2.5B | $2.5B | ||
| Q3 25 | $2.5B | $2.7B | ||
| Q2 25 | $2.5B | $2.6B | ||
| Q1 25 | $2.5B | $2.1B | ||
| Q4 24 | $2.5B | $2.0B | ||
| Q3 24 | $2.5B | $2.0B | ||
| Q2 24 | $2.5B | $2.0B | ||
| Q1 24 | $2.6B | $2.2B |
股东权益HOLXRPM
| Q4 25 | $5.2B | $3.1B | ||
| Q3 25 | $5.0B | $3.1B | ||
| Q2 25 | $4.8B | $2.9B | ||
| Q1 25 | $4.6B | $2.7B | ||
| Q4 24 | $4.8B | $2.7B | ||
| Q3 24 | $5.1B | $2.6B | ||
| Q2 24 | $5.0B | $2.5B | ||
| Q1 24 | $4.8B | $2.3B |
总资产HOLXRPM
| Q4 25 | $9.2B | $7.9B | ||
| Q3 25 | $9.0B | $7.9B | ||
| Q2 25 | $8.8B | $7.8B | ||
| Q1 25 | $8.5B | $6.6B | ||
| Q4 24 | $8.7B | $6.7B | ||
| Q3 24 | $9.2B | $6.6B | ||
| Q2 24 | $8.9B | $6.6B | ||
| Q1 24 | $8.7B | $6.4B |
负债/权益比HOLXRPM
| Q4 25 | 0.48× | 0.80× | ||
| Q3 25 | 0.50× | 0.87× | ||
| Q2 25 | 0.52× | 0.91× | ||
| Q1 25 | 0.55× | 0.78× | ||
| Q4 24 | 0.53× | 0.74× | ||
| Q3 24 | 0.49× | 0.77× | ||
| Q2 24 | 0.51× | 0.79× | ||
| Q1 24 | 0.53× | 0.93× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $229.9M | $345.7M |
| 自由现金流经营现金流 - 资本支出 | $215.2M | $296.4M |
| 自由现金流率自由现金流/营收 | 20.5% | 15.5% |
| 资本支出强度资本支出/营收 | 1.4% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.28× | 2.14× |
| 过去12个月自由现金流最近4个季度 | $1.0B | $582.9M |
8季度趋势，按日历期对齐
经营现金流HOLXRPM
| Q4 25 | $229.9M | $345.7M | ||
| Q3 25 | $355.1M | $237.5M | ||
| Q2 25 | $343.3M | $149.2M | ||
| Q1 25 | $169.4M | $91.5M | ||
| Q4 24 | $189.3M | $279.4M | ||
| Q3 24 | $367.0M | $248.1M | ||
| Q2 24 | $405.8M | $181.2M | ||
| Q1 24 | $292.4M | $173.4M |
自由现金流HOLXRPM
| Q4 25 | $215.2M | $296.4M | ||
| Q3 25 | $341.4M | $175.0M | ||
| Q2 25 | $330.5M | $78.2M | ||
| Q1 25 | $153.9M | $33.3M | ||
| Q4 24 | $172.5M | $229.5M | ||
| Q3 24 | $350.6M | $197.3M | ||
| Q2 24 | $385.3M | $105.3M | ||
| Q1 24 | $279.6M | $124.6M |
自由现金流率HOLXRPM
| Q4 25 | 20.5% | 15.5% | ||
| Q3 25 | 32.5% | 8.3% | ||
| Q2 25 | 32.3% | 3.8% | ||
| Q1 25 | 15.3% | 2.3% | ||
| Q4 24 | 16.9% | 12.4% | ||
| Q3 24 | 35.5% | 10.0% | ||
| Q2 24 | 38.1% | 5.2% | ||
| Q1 24 | 27.5% | 8.2% |
资本支出强度HOLXRPM
| Q4 25 | 1.4% | 2.6% | ||
| Q3 25 | 1.3% | 3.0% | ||
| Q2 25 | 1.3% | 3.4% | ||
| Q1 25 | 1.5% | 3.9% | ||
| Q4 24 | 1.6% | 2.7% | ||
| Q3 24 | 1.7% | 2.6% | ||
| Q2 24 | 2.0% | 3.8% | ||
| Q1 24 | 1.3% | 3.2% |
现金转化率HOLXRPM
| Q4 25 | 1.28× | 2.14× | ||
| Q3 25 | 1.90× | 1.04× | ||
| Q2 25 | 1.76× | 0.66× | ||
| Q1 25 | — | 1.76× | ||
| Q4 24 | 0.94× | 1.53× | ||
| Q3 24 | 2.05× | 1.09× | ||
| Q2 24 | 2.09× | 1.00× | ||
| Q1 24 | 1.72× | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HOLX
| Molecular Diagnostics | $255.3M | 24% |
| Breast Imaging | $219.9M | 21% |
| Services | $216.4M | 21% |
| Capital Equipment Componentsand Software | $187.2M | 18% |
| Cytology Perinatal | $76.0M | 7% |
| Interventional Breast Solutions | $71.2M | 7% |
| Blood Screening | $8.4M | 1% |
| Other Typeof Revenue | $5.4M | 1% |
RPM
| Construction Products Group Segment | $737.4M | 39% |
| Consumer Segment | $638.6M | 33% |
| Performance Coatings Group Segment | $533.8M | 28% |
